Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes;Sedentarismo y sobrepeso como factores de riesgo en la detección del cáncer de próstata y su agresividad

Actas Urologicas Espanolas

Volumn 38, Issue 4, 2014, Pages 232-237

  Morote, J ^a,b   Celma, A ^a   Planas, J ^a   Placer, J ^a   Konstantinidis, C ^a   Iztueta, I ^a   De Torres, I M ^a,b   Olivan M ^a   Reventos J ^a,c   Doll, A ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Obesity; Physical activity; Prostate cancer

Indexed keywords

AGED; BIOPSY; COMPLICATION; HUMAN; MALE; MIDDLE AGED; OBESITY; PATHOLOGY; PROSTATIC NEOPLASMS; RISK FACTOR; SEDENTARY LIFESTYLE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; PROSTATIC NEOPLASMS; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 84899926041     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2013.09.001     Document Type: Article

References (27)

1. M.M. Center, A. Jemal, J. Lortet-Tieulent, E. Ward, J. Ferlay, and O. Brawley et al. International variation in prostate cancer incidence and mortality rates Eur Urol 61 2012 1079 1092
2. J.M. Cózar, B. Miñana, F. Gómez-Veiga, A. Rodríguez-Antolín, H. Villavicencio, and A. Cantalapiedra et al. National prostate cancer registry 2010 in Spain Actas Urol Esp 37 2013 12 19
3. E.H. Allott, E.M. Masko, and S.J. Freedland Obesity and prostate cancer: Weighing the evidence Eur Urol 63 2013 800 809
4. A. Berghofer, T. Pischon, T. Reinhold, C.M. Apovian, A.M. Sharma, and S.N. Willich Obesity prevalence from a European perspective: A systematic review BMC Public Health 8 2008 200
5. Y. Liu, F. Hu, D. Li, F. Wang, L. Zhu, and W. Chen et al. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis Eur Urol 60 2011 1029 1044
6. L.H. Kushi, T. Byers, C. Doyle, E.V. Bandera, M. McCullough, and A. McTiernan et al. Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity CA Cancer J Clin 56 2006 254 281
7. E.M. Masko, E.H. Allott, and S.J. Freedland The relationship between nutrition and prostate cancer: Is more always better Eur Urol 63 2013 810 820
8. M. Remzi, Y. Fong, M. Dobrovits, T. Anagnostou, C. Seitz, and M. Waldert et al. The Vienna nomogram: Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume J Urol 174 2005 1256 1260
9. A. D'Amico, R. Whittington, S. Malkowicz, J. Fondurulia, M.H. Chen, and J.E. Tomaszewski et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
10. A.V. Patel, C. Rodriguez, E.J. Jacobs, L. Solomon, M.J. Thun, and E.E. Calle et al. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men Cancer Epidemiol Biomarkers Prev 14 2005 275 279
11. N.F. Johnsen, A. Tjonneland, B.L. Thomsen, J. Christensen, S. Loft, and C. Friedenreich et al. Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort Int J Cancer 125 2009 902 908
12. T.I. Nilsen, P.R. Romundstad, and L.J. Vatten Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study) Int J Cancer 119 2006 2943 2947
13. J. Antonelli, L.W. Jones, L.L. Bañez, J.A. Thomas, K. Anderson, and L.A. Taylor et al. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy J Urol 182 2009 2226 2231
14. A. McTiernan Mechanisms linking physical activity with cancer Nat Rev Cancer 8 2008 205 211
15. C.M. Friedenreich, and I. Thune A review of physical activity and prostate cancer risk Cancer Causes Control 12 2001 461 475
16. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass indexandincidenceof cancer: A systematic reviewandmeta-analysis of prospective observational studies Lancet 371 2008 569 578
17. R.J. MacInnis, and D.R. English Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis Cancer Causes Control 17 2006 989 1003
18. A. Bergstrom, P. Pisani, V. Tenet, A. Wolk, and H.O. Adami Overweight as an avoidable cause of cancer in Europe Int J Cancer 91 2001 421 430
19. A. Engeland, S. Tretli, and T. Bjorge Height, body mass index, and prostate cancer: A follow-up of 950,000 Norwegian men Br J Cancer 89 2003 1237 1242
20. S.O. Andersson, A. Wolk, R. Bergstrom, H.O. Adami, G. Engholm, and A. Englund et al. Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers J Natl Cancer Inst 89 1997 385 389
21. A. Discacciati, N. Orsini, and A. Wolk Body mass index and incidence of localized and advanced prostate cancer - a dose-response metaanalysis of prospective studies Ann Oncol 23 2012 1665 1671
22. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet, and M. Egger Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis Lancet 363 2004 1346 1353
23. J. Morote, J. Ropero, J. Planas, J.M. Bastarós, G. Delgado, and J. Placer et al. Metabolic syndrome increases the risk of aggresive prostate cancer detection BJU Int 111 2013 1031 1036
24. S. Yao, C. Till, A.R. Kristal, P.J. Goodman, A.W. Hsing, and C.M. Tangen et al. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: A nested case control study Cancer Causes Control 22 2011 1121 1131
25. H. Li, M.J. Stampfer, L. Mucci, W. Qiu, T. Kurth, and J. Ma A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival Clin Chem 56 2010 34 43
26. A. Azevedo, V. Cunha, A.L. Teixeira, and R. Medeiros IL-6/IL-6R as a potential key signaling pathway in prostate cancer development World J Clin Oncol 2 2011 384 396 27
27. S. Sharad, A. Srivastava, S. Ravulapalli, P. Parker, Y. Chen, and H. Li et al. Prostate cancer gene expression signature of patients with high body mass index Prostate Cancer Prostatic Dis 14 2011 22 29